Utama › Obesiti › New Hampshire

Kajian klinikal Obesiti di New Hampshire

3 kajian untuk Obesiti sedang mencari peserta di lokasi di New Hampshire.

Teks kajian rasmi (Bahasa Inggeris)

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Dartmouth-Hitchcock Medical Center, Lebanon

Mengambil pesertaFasa 3

Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Dartmouth-Hitchcock Medical Center, Lebanon

Mengambil pesertaFasa 3

Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06937086

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Stracskin, Portsmouth

Mengambil pesertaFasa 4

Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT06857942

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.